Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Migraine prophylaxis: what is new and what we need?

Literature DB >> 21533725

Migraine prophylaxis: what is new and what we need?

Abstract

A wide array of options are now available for migraine prophylaxis. Conventional treatments include beta-blockers, anticonvulsants, antidepressants, calcium antagonists and antiserotoninergic drugs. Emerging medications such as ACE inhibitors, sartans and nutritional supplements are gaining favour for migraine prophylaxis. Botulinum toxin type A is a promising therapeutic tool for chronic migraine. Tonabersat is likely to be a step forward for the treatment of migraine with aura. However, much work is needed to identify predictive clinical features of successful responsiveness and to better define the duration of prophylaxis.

Entities: Disease

Mesh：

Substances：
Analgesics

Year: 2011 PMID： 21533725 DOI： 10.1007/s10072-011-0526-3

Source DB: PubMed Journal: Neurol Sci ISSN： 1590-1874 Impact factor: 3.307

32 in total

1. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.

Authors: S K Aurora; D W Dodick; C C Turkel; R E DeGryse; S D Silberstein; R B Lipton; H C Diener; M F Brin
Journal: Cephalalgia Date: 2010-03-17 Impact factor: 6.292

Review 2. Prophylaxis of migraine headache.

Authors: Tamara Pringsheim; W Jeptha Davenport; Werner J Becker
Journal: CMAJ Date: 2010-02-16 Impact factor: 8.262

3. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial.

Authors: J Schoenen; J Jacquy; M Lenaerts
Journal: Neurology Date: 1998-02 Impact factor: 9.910

4. Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

Authors: R B Lipton; W F Stewart; S Diamond; M L Diamond; M Reed
Journal: Headache Date: 2001 Jul-Aug Impact factor: 5.887

5. Efficacy of gabapentin in migraine prophylaxis.

Authors: N T Mathew; A Rapoport; J Saper; L Magnus; J Klapper; N Ramadan; B Stacey; S Tepper
Journal: Headache Date: 2001-02 Impact factor: 5.887

6. Increased rate of major malformations in offspring exposed to valproate during pregnancy.

Authors: D F Wyszynski; M Nambisan; T Surve; R M Alsdorf; C R Smith; L B Holmes
Journal: Neurology Date: 2005-03-22 Impact factor: 9.910

7. A comparison between placebo, pizotifen and 1-isopropyl-3-hydroxy-5-semicarbazono-6-oxo-2.3.5.6-tetrahydroindol (Divascan) in migraine prophylaxis.

Authors: P O Osterman
Journal: Acta Neurol Scand Date: 1977-07 Impact factor: 3.209

Review 8. Tricyclic antidepressants and headaches: systematic review and meta-analysis.

Authors: Jeffrey L Jackson; William Shimeall; Laura Sessums; Kent J Dezee; Dorothy Becher; Margretta Diemer; Elizabeth Berbano; Patrick G O'Malley
Journal: BMJ Date: 2010-10-20

9. Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study.

Authors: Anne W Hauge; Mohammed S Asghar; Henrik W Schytz; Karl Christensen; Jes Olesen
Journal: Lancet Neurol Date: 2009-06-29 Impact factor: 44.182

10. Efficacy of lisinopril in migraine prophylaxis--an open label study.

Authors: S Schuh-Hofer; U Flach; A Meisel; H Israel; U Reuter; G Arnold
Journal: Eur J Neurol Date: 2007-06 Impact factor: 6.089

6 in total

1. Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Preventative Treatment of Episodic Migraine in Adults.

Authors: T Dorosch; C A Ganzer; M Lin; A Seifan
Journal: Curr Pain Headache Rep Date: 2019-09-12

Review 2. Exercise in Treatment of Migraine Including Chronic Migraine.

Authors: Tae-Jin Song; Min Kyung Chu
Journal: Curr Pain Headache Rep Date: 2021-02-25

3. Progesterone receptor gene (PROGINS) polymorphism correlates with late onset of migraine.

Authors: Raffaele Palmirotta; Piero Barbanti; Cristiano Ialongo; Maria Laura De Marchis; Jhessica Alessandroni; Gabriella Egeo; Cinzia Aurilia; Luisa Fofi; Maria Giovanna Valente; Patrizia Ferroni; David Della-Morte; Fiorella Guadagni
Journal: DNA Cell Biol Date: 2014-12-10 Impact factor: 3.311